Catalyst Event
Teva Pharmaceutical Industries Ltd (TEVA) · Earnings Release
From KEDI Global Longevity Bio Index (KGLB)
4/29/2026, 12:00:00 AM
Teva is scheduled to release its first quarter 2026 financial results and host a conference call on April 29, 2026; importance is estimated at Medium as earnings reports typically drive significant price volatility, expected.
Korean Translation
실적 발표는 통상적으로 유의미한 주가 변동을 수반하므로 중요도를 'Medium'으로 예상하며, 2026년 4월 29일 2026년 1분기 실적 발표 및 컨퍼런스 콜 개최가 예정됨.
Related Recent Events
Ionis Pharmaceuticals Inc (IONS) · Other
FDA target action (PDUFA) date for olezarsen for the treatment of severe hypertriglyceridemia (sHTG) following acceptance of sNDA for Priority Review. This is a major potential approval for a broad patient population, scheduled.
6/30/2026, 12:00:00 AM
Biogen Inc (BIIB) · Earnings Release
Q1 2026 earnings release (Low impact estimated as routine earnings releases typically see at least 1% volatility) scheduled.
5/6/2026, 12:00:00 AM
Bristol-Myers Squibb Co (BMY) · Earnings Release
Bristol-Myers Squibb is scheduled to announce its first-quarter 2026 financial results on April 30, 2026, scheduled.
4/30/2026, 12:00:00 AM
Eli Lilly and Co (LLY) · Earnings Release
Q1 2026 earnings release scheduled; a price impact of at least 1% is expected.
4/30/2026, 12:00:00 AM
Sanofi (SNY) · Earnings Release
First quarter 2026 earnings results are scheduled to be released on April 23, 2026. This is expected to have a low impact as a routine financial update, scheduled.
4/23/2026, 12:00:00 AM
Medpace Holdings Inc (MEDP) · Earnings Release
Q1 2026 earnings release is scheduled. Analysts forecast EPS of approximately $3.90 - $4.01 and revenue around $697.82M. Medium importance is estimated based on historical earnings volatility exceeding 5% scheduled.
4/20/2026, 12:00:00 AM